Letter

Cervical cancer screening: Liquid based cytology may be preferred option for UK screening programme

BMJ 2003; 327 doi: 10.1136/bmj.327.7407.161-a (Published 17 July 2003)
Cite this as: BMJ 2003;327:161.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Thomas Ind (ind@tomind.freeserve.co.uk), consultant gynaecological oncologist
  1. Royal Marsden Hospital, London SW3 6JJ

    EDITOR—Coste et al studied conventional cervical smear testing, monolayer cytology, and human papillomavirus DNA testing for cervical screening, their results being published as the National Institute for Clinical Excellence (NICE) was deciding whether liquid based cytology should be used in the United Kingdom.1 Thus the paper must be interpreted in relation to others with assessment of its relevance to the NHS …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular